TGFβ1 treatment in breast cancer cells triggers active CDK5/p35 to phosphorylate Focal Adhesion Kinase (FAK) at S732, causing metastatic invasion and EMT by potentiating F-actin bundle formation [42] (Fig. 1A). Here, CDK5R1 is linked to breast carcinoma.